Building Resilience through Manufacturing Optionality
Building Resilience Through Manufacturing Optionality: How Abingdon Health’s Dual-Site Strategy Delivers Certainty in Uncertain Times
In today’s volatile economic and geopolitical climate, manufacturing optionality isn’t just a competitive advantage—it’s a strategic imperative for companies serving global markets. At Abingdon Health, we’ve built our manufacturing strategy around this principle, establishing mirror capabilities across two strategically located facilities that provide our customers with unparalleled flexibility and security. Abingdon Health’s Chief Operating Officer, Mark Jones, outlines our approach below.
The New Reality of Global Manufacturing
The past few years have fundamentally reshaped how we think about manufacturing resilience. Geopolitical tensions continue to create unexpected trade barriers, while natural disasters and global events can shut down entire supply chains overnight. Meanwhile, evolving regulatory landscapes and shifting government incentives are encouraging companies to reconsider their manufacturing footprints.
For companies in the life sciences and diagnostics sectors, these challenges are particularly acute. Regulatory compliance requirements vary significantly between regions, and the need for rapid response to market demands has never been greater. This is where Abingdon Health’s approach to manufacturing optionality becomes a game-changer.
Our Twin-Site Advantage: York and Madison
Abingdon Health operates state-of-the-art manufacturing facilities in both York, UK and Madison, USA—a strategic positioning that places us at the heart of two of the world’s most important regulatory and commercial regions. What makes our approach unique isn’t just having facilities on both sides of the Atlantic; it’s how we’ve designed these operations to work as true mirror sites.
Both our York and Madison facilities operate using identical equipment specifications and follow the same Standard Operating Procedures (SOPs). This isn’t just operational efficiency—it’s strategic resilience. When our customers work with us, they’re not just accessing one manufacturing site; they’re gaining entry to a truly flexible production network that can adapt to their changing needs without compromising on quality or compliance.
Our cross-functional expertise spans both locations, with deep knowledge in technical operations, supply chain management, quality assurance, and regulatory affairs. This means we can deliver the same exacting standards whether production takes place in Yorkshire or Wisconsin, ensuring our customers receive consistent, high-quality products regardless of which facility serves their needs.
Responding to Market Realities
The benefits of this dual-site approach extend far beyond simple geographic diversification. When tariff pressures emerge—as they have repeatedly in recent years—we can shift production to optimise cost structures for our customers. If regulatory changes favor one jurisdiction over another, we have the flexibility to adapt quickly without disrupting supply chains.
Our local-for-local strategy means that wherever possible, we source materials and talent regionally around each facility. For example, it’s not just about “being manufactured in the US” it’s also about the supply chain being “procured in the US”. This approach not only enhances supply security but also supports local economies while reducing our environmental footprint through shorter transportation distances.
The proximity of our facilities to key markets delivers tangible benefits. Our York site serves European customers and North American customers wanting local manufacturing to access the European and Middle Eastern markets with shorter lead times and enhanced responsiveness, while our Madison facility does the same for North American markets. This geographic positioning allows us to operate with leaner inventory levels, freeing up working capital for our customers while maintaining the agility to respond quickly to market demands.
Risk Mitigation Through Design
Perhaps most importantly, our twin-site strategy means that our customers never face the risk of total production disruption. Political unrest, natural disasters, or unexpected regulatory shifts in one region won’t paralyse operations because we can seamlessly shift production to our other facility. This built-in redundancy provides the kind of business continuity assurance that’s become invaluable in today’s uncertain world.
The COVID-19 pandemic demonstrated the vulnerability of single-site manufacturing strategies. Companies with concentrated production faced difficult choices between shutting down entirely or operating under compromised conditions. Our distributed approach meant we could maintain operations and continue serving customers even when one region faced restrictions.
Innovation Through Optionality
Our dual-site capability also enhances our innovation potential. Each facility taps into its local R&D ecosystem—connecting with universities, research institutions, and innovation clusters that provide unique insights and capabilities. The York facility benefits from the UK’s strong life sciences research base, while Madison leverages the robust American biotech and medtech innovation environment. Madison was recently awarded $49m in federal funding as part of the Wisconsin Biotech Health Hub and has world class research infrastructure with the University of Wisconsin-Madison ranking 6th nationally in research expenditure.
This geographical diversity in our innovation inputs translates into better solutions for our customers. We can tailor products to meet specific market needs with regionally focused production capabilities, while our standardised processes ensure that innovations developed at one site can be rapidly deployed at the other.
Building Customer Confidence
Ultimately, our manufacturing optionality strategy is about building customer confidence. In a world where supply chain disruptions have become the norm rather than the exception, our customers know they can rely on Abingdon Health to deliver. Whether facing a global pandemic, port strikes, or unexpected regulatory changes, our dual-site capability means we’re never caught flat-footed.
This reliability builds the kind of trust and loyalty that creates lasting partnerships. Our customers can focus on their core business objectives, knowing that their manufacturing partner has built resilience into every aspect of the relationship.
Looking Forward
As we look to the future, the drivers that make manufacturing optionality essential are only intensifying. Geopolitical tensions show no signs of abating, environmental regulations continue to evolve, and the pace of technological change demands ever-greater agility from manufacturing partners.
At Abingdon Health, our investment in twin-site manufacturing capabilities with identical equipment and SOPs positions us—and our customers—to thrive in this environment. We’ve built our business around the understanding that in an uncertain world, optionality isn’t just valuable—it’s essential.
By choosing Abingdon Health as your manufacturing partner, you’re not just accessing our technical capabilities; you’re gaining a strategic advantage that provides security, flexibility, and peace of mind in an increasingly complex global marketplace.
Abingdon Health’s team has over 20 years’ experience in the lateral flow market and provides Development, Scale-Up & Manufacturing, Regulatory and Performance Evaluation services all under one roof ensuring seamless and parallel workstreams saving you time and money. If you would like to discuss any specific requirements don’t hesitate to contact Abingdon Health’s highly experienced team.
